Showing 1 to 5 of 5 results


New Epigenetic Method Predicts Cancer Progression
A new study published in Nature reveals an epigenetic method to predict cancer progression by analyzing methylation patterns in tumor cells, offering insights into the tumor's evolutionary history and potentially improving treatment strategies.
New Epigenetic Method Predicts Cancer Progression
A new study published in Nature reveals an epigenetic method to predict cancer progression by analyzing methylation patterns in tumor cells, offering insights into the tumor's evolutionary history and potentially improving treatment strategies.
Progress
12% Bias Score


New Biomarker Predicts Alzheimer's Cognitive Decline
Researchers at Stanford University have discovered a new biomarker—a ratio of two synaptic proteins (YWHAG and NPTX2)—that accurately predicts cognitive decline in Alzheimer's disease, potentially improving early diagnosis and treatment selection.
New Biomarker Predicts Alzheimer's Cognitive Decline
Researchers at Stanford University have discovered a new biomarker—a ratio of two synaptic proteins (YWHAG and NPTX2)—that accurately predicts cognitive decline in Alzheimer's disease, potentially improving early diagnosis and treatment selection.
Progress
24% Bias Score


OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
OxiDx's New Blood Test Detects Muscle Damage, Revolutionizing Sports Medicine
OxiDx, a Proteomics International subsidiary, unveiled a new fingerprick blood test accurately measuring muscle damage via oxidative stress biomarkers in 20 elite marathon runners, with results published in Physiological Reports, showing potential for personalized recovery and broader medical applic...
Progress
48% Bias Score

Blood Test Predicts Motor Neurone Disease a Decade Early
A new blood test can identify specific proteins indicating Amyotrophic Lateral Sclerosis (ALS), the most common form of motor neurone disease, up to 10 years before symptom onset, according to a Johns Hopkins University study published in Nature Medicine.

Blood Test Predicts Motor Neurone Disease a Decade Early
A new blood test can identify specific proteins indicating Amyotrophic Lateral Sclerosis (ALS), the most common form of motor neurone disease, up to 10 years before symptom onset, according to a Johns Hopkins University study published in Nature Medicine.
Progress
52% Bias Score

CD74 Protein Identified as Potential Biomarker for Colorectal Cancer Immunotherapy Response
Researchers have identified the protein CD74 as a potential biomarker to predict immunotherapy response in colorectal cancer patients, improving treatment selection and potentially expanding access to immunotherapy.

CD74 Protein Identified as Potential Biomarker for Colorectal Cancer Immunotherapy Response
Researchers have identified the protein CD74 as a potential biomarker to predict immunotherapy response in colorectal cancer patients, improving treatment selection and potentially expanding access to immunotherapy.
Progress
44% Bias Score
Showing 1 to 5 of 5 results